111 related articles for article (PubMed ID: 26759836)
21. Chiral inversion of 2-arylpropionyl-CoA esters by human α-methylacyl-CoA racemase 1A (P504S)--a potential mechanism for the anti-cancer effects of ibuprofen.
Woodman TJ; Wood PJ; Thompson AS; Hutchings TJ; Steel GR; Jiao P; Threadgill MD; Lloyd MD
Chem Commun (Camb); 2011 Jul; 47(26):7332-4. PubMed ID: 21614403
[TBL] [Abstract][Full Text] [Related]
22. The perils of rational design--unexpected irreversible elimination of fluoride from 3-fluoro-2-methylacyl-CoA esters catalysed by α-methylacyl-CoA racemase (AMACR; P504S).
Yevglevskis M; Lee GL; Threadgill MD; Woodman TJ; Lloyd MD
Chem Commun (Camb); 2014 Nov; 50(91):14164-6. PubMed ID: 25277991
[TBL] [Abstract][Full Text] [Related]
23. A study on the AMACR catalysed elimination reaction and its application to inhibitor testing.
Yevglevskis M; Lee GL; Sun J; Zhou S; Sun X; Kociok-Köhn G; James TD; Woodman TJ; Lloyd MD
Org Biomol Chem; 2016 Jan; 14(2):612-622. PubMed ID: 26537174
[TBL] [Abstract][Full Text] [Related]
24. Design and evaluation of substrate-product analog inhibitors for racemases and epimerases utilizing a 1,1-proton transfer mechanism.
Bearne SL
Methods Enzymol; 2023; 690():397-444. PubMed ID: 37858537
[TBL] [Abstract][Full Text] [Related]
25. Purification and properties of an alpha-methylacyl-CoA racemase from rat liver.
Schmitz W; Fingerhut R; Conzelmann E
Eur J Biochem; 1994 Jun; 222(2):313-23. PubMed ID: 8020470
[TBL] [Abstract][Full Text] [Related]
26. Crystal structure of fatty acid-CoA racemase from Mycobacterium tuberculosis H37Rv.
Lee KS; Park SM; Rhee KH; Bang WG; Hwang KY; Chi YM
Proteins; 2006 Aug; 64(3):817-22. PubMed ID: 16755588
[No Abstract] [Full Text] [Related]
27. Relationship between alpha-methylacyl-coenzyme A racemase expression and mucin phenotype in gastric cancer.
Nozawa Y; Nishikura K; Ajioka Y; Aoyagi Y
Hum Pathol; 2012 Jun; 43(6):878-87. PubMed ID: 22078291
[TBL] [Abstract][Full Text] [Related]
28. Unexpected stereoselective exchange of straight-chain fatty acyl-CoA alpha-protons by human alpha-methylacyl-CoA racemase 1A (P504S).
Sattar FA; Darley DJ; Politano F; Woodman TJ; Threadgill MD; Lloyd MD
Chem Commun (Camb); 2010 May; 46(19):3348-50. PubMed ID: 20442897
[TBL] [Abstract][Full Text] [Related]
29. Occurrence of pyridoxal 5'-phosphate-dependent serine racemase in silkworm, Bombyx mori.
Uo T; Yoshimura T; Shimizu S; Esaki N
Biochem Biophys Res Commun; 1998 May; 246(1):31-4. PubMed ID: 9600063
[TBL] [Abstract][Full Text] [Related]
30. In silico and pharmacological screenings identify novel serine racemase inhibitors.
Mori H; Wada R; Li J; Ishimoto T; Mizuguchi M; Obita T; Gouda H; Hirono S; Toyooka N
Bioorg Med Chem Lett; 2014 Aug; 24(16):3732-5. PubMed ID: 25066953
[TBL] [Abstract][Full Text] [Related]
31. A continuous assay for alpha-methylacyl-coenzyme A racemase using circular dichroism.
Ouazia D; Bearne SL
Anal Biochem; 2010 Mar; 398(1):45-51. PubMed ID: 19854148
[TBL] [Abstract][Full Text] [Related]
32. Malonate-based inhibitors of mammalian serine racemase: kinetic characterization and structure-based computational study.
Vorlová B; Nachtigallová D; Jirásková-Vaníčková J; Ajani H; Jansa P; Rezáč J; Fanfrlík J; Otyepka M; Hobza P; Konvalinka J; Lepšík M
Eur J Med Chem; 2015 Jan; 89():189-97. PubMed ID: 25462239
[TBL] [Abstract][Full Text] [Related]
33. Racemases and epimerases operating through a 1,1-proton transfer mechanism: reactivity, mechanism and inhibition.
Lloyd MD; Yevglevskis M; Nathubhai A; James TD; Threadgill MD; Woodman TJ
Chem Soc Rev; 2021 May; 50(10):5952-5984. PubMed ID: 34027955
[TBL] [Abstract][Full Text] [Related]
34. Structure-aided design of inhibitors of Mycobacterium tuberculosis thymidylate kinase.
Van Calenbergh S
Verh K Acad Geneeskd Belg; 2006; 68(4):223-48. PubMed ID: 17214439
[TBL] [Abstract][Full Text] [Related]
35. Role of alpha-methylacyl coenzyme A racemase in the degradation of methyl-branched alkanes by Mycobacterium sp. strain P101.
Sakai Y; Takahashi H; Wakasa Y; Kotani T; Yurimoto H; Miyachi N; Van Veldhoven PP; Kato N
J Bacteriol; 2004 Nov; 186(21):7214-20. PubMed ID: 15489432
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of alpha-methylacyl-coA racemase among men with high grade prostatic intraepithelial neoplasia in prostate biopsies.
Stewart J; Fleshner N; Cole H; Toi A; Sweet J
J Urol; 2008 May; 179(5):1751-5; discussion 1755. PubMed ID: 18343427
[TBL] [Abstract][Full Text] [Related]
37. Antituberculars which target decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1: state of art.
Buroni S; Pasca MR; de Jesus Lopes Ribeiro AL; Degiacomi G; Molteni E; Riccardi G
Appl Microbiol Biotechnol; 2012 May; 94(4):907-16. PubMed ID: 22526781
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and evaluation of novel inhibitors for wild-type human serine racemase.
Takahara S; Nakagawa K; Uchiyama T; Yoshida T; Matsumoto K; Kawasumi Y; Mizuguchi M; Obita T; Watanabe Y; Hayakawa D; Gouda H; Mori H; Toyooka N
Bioorg Med Chem Lett; 2018 Feb; 28(3):441-445. PubMed ID: 29277459
[TBL] [Abstract][Full Text] [Related]
39. α-Methyl Acyl CoA Racemase Provides Mycobacterium tuberculosis Catabolic Access to Cholesterol Esters.
Lu R; Schmitz W; Sampson NS
Biochemistry; 2015 Sep; 54(37):5669-72. PubMed ID: 26348625
[TBL] [Abstract][Full Text] [Related]
40. Dual substrate and reaction specificity in mouse serine racemase: identification of high-affinity dicarboxylate substrate and inhibitors and analysis of the beta-eliminase activity.
Strísovský K; Jirásková J; Mikulová A; Rulísek L; Konvalinka J
Biochemistry; 2005 Oct; 44(39):13091-100. PubMed ID: 16185077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
